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1. introduction 
It has been shown that wild type strains of E. coli 
resistant to chloramphenicol (Cm) are able to acety- 
late this drug. The synthesis of the acetylase is control- 
led by an extrachromosomal element (= plasmid), 
which can be transferred, from the resistant E. coli, to 
sensitive cells. In some cases, the plasmid is not trans- 
ferable although the resistance is due to the same me- 
chanism. With chloramphenicol resistant mutants, 
selected in vitro, we have not been able to demonstrate 
such a reaction [l] . The acetylation occurs mainly in 
positions 1 and 3 (1,3-diacetoxy-chloramphenicol) or 
in position 3 (3-monoacetoxy-chloramphenicol) [I, 2] 
Fig. 1. represents a molecule of the drug with the posi- 
tions 1,2 and 3 indicated. 
To investigate further the mechanism of resistance 
to chloramphenicol, the effect of the acetylated com- 
pounds of the drug was tested on protein synthesis in 
E. coli, in vivo and in vitro with polyuridylic acid or 
viral RNA as messenger. It was found that chloram- 
phenicol and the acetylated compounds showed the 
same pattern of inhibition in vitro, as they did in vivo: 
the inhibition decreased with mono-acetylation and 
nearly disappeared with di-acetylation. 
2. Materials and methods 
The 3-acetoxy-Cm and 1,3-diacetoxy-Cm were a 
kind gift from Dr.Suzuki (Japanese National Institute 
of Health). We also made some preparations of these 
compounds as follows: R265, a Cm-resistant wild type 
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strain of E. coli (a clinical isolate) was grown in a 5 
liter nutrient broth (Difco) in presence of chloram- 
phenicol(200 pglml) to late log phase; Cm and its 
acetylated derivatives were extracted by ether; the 
organic phase was evaporated in vucuo, redissolved in 
5 ml ethanol, purified on charcoal, filtered and 
finally evaporated to a 1 ml volume. The acetylated 
compounds were separated by thin layer chromato- 
graphy [I]. The corresponding spots were eluted 
with ethanol and these solutions evaporated again to 
1 ml volume. 
Fig. 1. The chloramphenicol molecule with positions 1 and 3. 
3. Experiments and results 
We first determined the Minimum Inhibitory Con- 
centration (MIC) of chloramphenicol (ARC0 Ltd., 
Switzerland) and of its acetylated compounds in 
nutrient broth. The values are reported in table 1. The 
growth of Cm-sensitive strains of E. coli was inhibited 
by 6 to 12 /.rg/ml of chloramphenicol, whereas 100 
I.cg/ml of the mono-acetylated compound were neces- 
sary to obtain the same order of inhibition. At a 
higher concentration ( 200 &ml), the diacetylated 
derivative was inactive. 
North-Holland Publishing Company - Amsterdam 
Volume 11, number 1 FEBS LETTERS November 1970 
7 
5 
Fig. 2. Incorporation of,labeled ammo acids (cts/min) in the presence of - Cm, u---o 3-Cm and - 1,3Cm (synthetic 
compounds) as a function of concentrations of Cm and Cm derivatives. The 200 l.‘i reaction mixture contained: 100 ~1 “mix” 
(1 ml tris-HCl, pH 7.4; 0.5 ml tRNA, 50 mg/ml; 0.4 ml ATP 0.05 M; 0.3 ml GTP 0.02 hi; 1 ml phosphoenolpyruvate 0.07 M; 
1.4 ml MgCla 0.1 M; 0.5 ml NH&l 4 M; 4.9 ml HaO); 10 ~1 pyruvate-kinase (1 mg/ml); 40 ~1 SlOO (crude extract-ribosome dia- 
lysed against ris 0.01 M, KC1 0.1 M and concentrated on G25 coarse); 100 clg 70 S ribosomes in 20 fi buffer MgCla 0.01 M; 10 
~1 ethanol 50% with or without Cm or its derivates: 10 111 phage R17 RNA; 10 4 amino acid mixture (mixture l/l v/v of r4C 
HLmixture and of a solution of the 20 cold ammo acids, 2 pmoles/ml); the mixture was adjusted to pH 7.0. Ribosomes and SlOO 
are extracted from E. coli MRE 600. The system was incubated 20 mm at 32’; 2 ml of a solution of TCA 51, casamino acids 3% 
are added and the tRNA is made soluble by heating at 9O’for 15 mm. The samples are then faltered on Millipore GFC and the tu- 
bes washed twice with TCA 5%, casamino acids 3%. The filters are dried and the radioactivity counted on Nuclear Chicago. 
The effect of Cm and its derivatives was then tested acetylated compounds; similar esults were obtained 
on an in vitro protein synthesizing system. With poly- with Cm by Kucan and Lipmann [3]. We then used 
U as messenger, no significant differences were obser- a native RNA messenger in our system. The incorpo- 
ved between samples with or without Cm and the ration of labelled amino-acids in the presence of 
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Table 1 
The minimum inhibitory concentrations of Cm and its acety- 
lated compounds (&ml). 
E. coli K12 E. coli wild type R376 
Cm 3-6 6-12 
3Cm 50-100 50-100 
1,3Cm > 200 > 200 
The sensitive strains used are: E. coli K12 p met- aziS str’ 
TIS T6S and E. cob R376, wild type (clinical isolate). 
chloramphenicol and its derivatives are reported in fig, 2. 
The values obtained show that the relative inhibitory 
activities of the three compounds tested are the same 
in vitro and in vivo: again in vitro the 3-acetoxy com- 
pound is less active than Cm, whereas the 1,3-diace- 
toxy is inactive. We observed no difference between 
the behaviour of the compounds we prepared biologi- 
cally and those synthesized by Dr.Suzuki, An unex- 
pected finding was the regain of amino-acid incorpo- 
ration w&h increasing concentrations of Cm. Identical 
results forthe inhibition of amino acid incorporation 
were o&ained if the ribosomes used in the cell-free 
system were obtained from resistant strains. 
4. Discussion 
The difference of activity between Cm and its 
acetylated derivatives and the decrease of effect of Cm 
with increasing concentrations cannot easily be ex- 
plained at this stage. However, from these two observa- 
tions, one could imagine a model in which two specific 
sites on the Cm molecule (carried on Cl and C,, fig. 1) 
correspond to two other sites in the protein synthesiz- 
ing system. According to Weisblum and Davies [4], 
these sites could be localized on the 50 S ribosomal 
subunit. In our model, both sites of the same Cm mo- 
lecule would be attached to the other corresponding 
sites in order to be completely active. If only one of 
the sites is free, the activity of the antibiotic is de- 
creased. This would explain the activities found in vivo 
and in vitro with the mono-acetylated compound. In ex- 
cess of Cm, the two sites of the protein synthesizing 
system would be occupied by two different Cm mole- 
cules and thus the antibiotic activity would be lessened. 
This would explain the lessening activity of Cm with 
increasing concentrations. 
To obtain further information on the reliability of 
our model, two types of experiments will have to be 
carried out. The binding of acetylated derivatives to 
the ribosomes should be determined in comparison 
with that of chloramphenicol and a quantitative study 
of the binding of chloramphenicol to the ribosomes 
should be done in relation to the ratio chloramphenicol/ 
ribosomes. 
Acknowledgements 
We thank Prof. Spahr for a gift of phage R17 RNA, 
and Prof. Tissieres for help. 
References 
[ 1) J.C.Piffaretti and J.S.Pitton, Chemotherapy 15 (1970) 84. 
[2] W.V.Shaw, J. Biol. Chem. 242 (1967) 687. 
[3] Z.Kucan and F.Lipmann, J. Biol. Chem. 239 (1964) 5 16. 
[4] B.Weisblum and J.Davies, Bacterial. Rev. 32 (1968) 493. 
28 
